Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 14, 2019 Off

Iktos Announces Collaboration with Merck KGaA, Darmstadt, Germany, for Use of Iktos AI Technology across Three Drug Discovery Projects

By BusinessWire

Iktos’ generative modelling AI technology enables rapid and
cost-effective design of novel drugs

Collaboration agreement enables Merck KGaA, Darmstadt, Germany
access to Iktos AI technology across…

March 14, 2019 Off

VenatoRx Pharmaceuticals’ Christopher J. Burns, Ph.D. Named CEO of the Year by Life Sciences Pennsylvania

By BusinessWire

Recognition honors a CEO who has demonstrated visionary leadership
and active participation to advance the life sciences and biotech
industry

MALVERN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/antibio…

March 14, 2019 Off

Altasciences Receives CRO Leadership Award in Five Categories

By BusinessWire

LAVAL, Quebec–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Altasciences?src=hash" target="_blank"gt;#Altascienceslt;/agt;–Altasciences,
a mid-size CRO specializing in a flexible, innovative approach to
pro…

March 14, 2019 Off

Walgreens Boots Alliance Names Heather Dixon Senior Vice President, Global Controller and Chief Accounting Officer

By BusinessWire

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today named Heather Dixon
as its new senior vice president, global controller and chief accounting
officer, effective March 18, 2019.

Dixon wil…

March 14, 2019 Off

Millendo Therapeutics Announces ENDO 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia

By BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo
Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage
biopharmaceutical company developing novel treatments for orphan
endocrine diseases, announced today that its clinical candidates,
…

March 14, 2019 Off

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Reviews Business Progress

By BusinessWire

— Edasalonexent Phase 3 PolarisDMD Trial Globally Enrolling Boys
with Duchenne Muscular Dystrophy —

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis
Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutica…

March 14, 2019 Off

EnClear Therapies Announces Seed Funding and Senior R&D Appointment

By BusinessWire

— $2 million in seed funding raised to advance development —

— Kevin Kalish joins EnClear as Vice-President of Research and
Development —

CAMBRIDGE, Mass.–(BUSINESS WIRE)–EnClear
Therapies, a biotechnol…

March 14, 2019 Off

KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

By BusinessWire

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial
Progressing –

– Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase
2 Trial Completion Expected H2 2019 –

– Oral Plasma …

March 14, 2019 Off

Betaseron – Drug Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Betaseron
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Betaseron Drug Insight, 2019 highlights the drug
marketed details and the Global API Manufact…

March 14, 2019 Off

Raymond Schinazi Joins Precision BioSciences Board of Directors

By BusinessWire

Globally recognized leader in antiviral drug discovery and development

DURHAM, N.C.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/celltherapy?src=hash" target="_blank"gt;#celltherapylt;/agt;–Precision BioSc…

Posts pagination

Previous 1 … 3,358 3,359 3,360 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine